Cortalix News and Events
Your source for the latest content from Cortalix news and events:
Latest News, Upcoming Events and Presentations
Meet Cortalix at CPHI Worldwide 2025 in Frankfurt
Meet Cortalix at CPHI Worldwide 2025 in Frankfurt Cortalix is excited to announce that we will be attending CPHI Worldwide 2025, held on 28–30 October in Frankfurt, Germany. CPHI is one of the largest global gatherings for the pharmaceutical industry, bringing...
Cortalix at Nordic Life Science Days 2025 in Gothenburg
Cortalix at Nordic Life Science Days 2025 in Gothenburg Cortalix is pleased to announce that we will be attending Nordic Life Science Days (NLSDays) 2025, which takes place on 13–14 October in Gothenburg, Sweden. NLSDays is the leading partnering conference for the...
Cortalix and UMCG join forces to develop next-generation nanobody-based CAR-T therapies
Cortalix has entered into a New Collaboration with University Medical Center Groningen, The Netherlands: Development of AI-Guided nano-CAR™ Library for Next-Generation CAR-T Therapy Cortalix has initiated a public-private research collaboration with the Department of...
CORTALIX will be present at Antibody Industrial Symposium (AIS) in Tours, France, June 25-26 2025
CORTALIX AIS 2025 – Booth #51 We’re excited to announce that Cortalix will be present at the 13th Antibody Industrial Symposium (AIS 2025), taking place June 25–26 at the Palais des Congrès in Tours, France. 📍 Booth #51👤 Herman Steen (CEO) and Ronald Vos (CBO) will be...
Cortalix joins forces with Portal Biotech, GECCO and RUG to enable portable nanobody-based diagnostics
Cortalix is pleased to announce its participation in a new EFRO-funded research collaboration with Portal Biotech, GECCO Biotech, and the University of Groningen (RUG). The project aims to develop a portable diagnostic platform based on innovative nanopore technology,...
Cortalix receives investment from Future Tech Ventures and Rabobank Innovation
Cortalix, a Groningen-based biotech start-up has received an investment of 1 million euros from Future Tech Ventures, the Rabobank Innovation Loan, and various subsidies to accelerate the development and commercialization of its single-domain antibody technology. The...
Cortalix will present at PepTalk San Diego, CA, January 13-16 2025
Herman Steen, CEO of Cortalix, will present on "Single-Domain Antibody-Based Radiopharmaceuticals for Novel Cancer Stroma Targets" at the 24th Annual PepTalk Summit US, January 13-16, 2025 in San Diego, CA. For more information about Cortalix: www.cortalix.com Contact...
Cortalix will present at Festival of Biologics in Basel, Switzerland, 15-17 October 2024
Herman Steen, CEO of Cortalix, will present a poster "A Synthetic Single-domain Antibody Discovery Platform for the Selection of Radiopharmaceuticals for Novel Fibrosis Targets" at the Festival of Biologics, October 15-17, 2024 in Basel, Switzerland. You are cordially...
Cortalix will present at TRP Berlin, Germany, 5 – 7 December 2023
Herman Steen, CEO of Cortalix, will present on "Novel Fibrosis Targets for Molecular Imaging of Fibrogenesis & Fibrotic Cancers" at the 5th Targeted Radiopharmaceuticals Summit EU 2023, December 5 - 7, 2023 in Berlin, Germany. For more information about Cortalix:...
Cortalix is awarded a EUROSTARS grant and joins the existing consortium on molecular diagnostic PET-imaging of colorectal cancer
Cortalix will join the existing consortium on a EUROSTARS grant of EUR 1.7 million for colorectal cancer molecular PET-imaging. EUROSTARS is a joint program of EUREKA and the European Commission, co-funded by the national budgets of 36 EUROSTARS Participating and...
Cortalix is a member of LIFE Cooperative a regional life sciences cooperative based in Groningen, and of HollandBIO, the national biotech industry association.